What 3 words would you use to describe your role? Intense, challenging, rewarding. What do you like most about working at Personalis? First, it gives me the possibility to keep learning. When I started, immuno-oncology was a new field for me, and it’s been great to learn about it. This is very important to me, [...]
A list of genes tested is located at this link.
The NeXT Dx Test helps identify potential therapies (targeted and immuno-therapies) and clinical trial options for cancer patients based on the tumor molecular profile.
The NeXT Dx Test is a laboratory developed test performed at Personalis’ CAP-accredited and CLIA’88- certified laboratory. It is intended for profiling a solid tumor’s genomic and molecular characteristics using clinical-grade, next-generation sequencing (NGS) technology to report small nucleotide variants (SNVs), small insertions and deletions (indels), copy number alterations (CNAs), and fusions in up to [...]